Jeffrey Jay, M.D., M.B.A. Email and Phone Number
Jeffrey Jay, M.D., M.B.A. work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jeffrey Jay, M.D., M.B.A. personal email
Jeffrey Jay, M.D., M.B.A. phone numbers
I am a Founder of one of the oldest and top performing health care investment firms in North America that manages approximately $2.0 billion through a life sciences hedge fund founded in 2000 and a series of four health care growth buy-out funds (GPP I, II, III & IV). Over my career I have overseen or been involved in the completion of over 200 investments in high growth companies and been cumulatively responsible for over five billion dollars of equity capital deployed. I have also been prominent in leading successful fundraising campaigns for highly regarded educational and health care institutions.
-
Founder, Managing Partner, Co-Portfolio Manager Of The Biomedical Value FundGreat Point Partners Oct 2003 - PresentGreenwich, Ct, UsGreat Point Partners, founded in 2003, manages approximately $2.0 billion of health care investments in the U.S., Canada and Western Europe through GPP I, II, III and IV private equity growth buy-out funds and the BioMedical Value Fund, ("BMVF") one of the world's first biotechnology long/short hedge funds, founded in 2000, for our limited partners who are endowments, foundations and family offices. We have separate private and public investment teams and 35 professionals in Greenwich, CT and London, UK. GPP's private equity funds are all in the top quartile of their vintage according to Cambridge Associates data. GPP I, a $156 million lower middle market, fully realized health care buy-out fund, has performed in the top quartile of its peer group (net TV/PI of 2.1x and net D/PI of 2.1x) for the 2006 vintage. GPP II is a 2013 vintage $215 million health care buy out fund, has a net TV/PI of 3.2x, net D/PI of 2.8x, net IRR 31%. GPP III a $306 million fund, activated in April 2019, is 100% invested and only mid-cycle yet has a net TV/PI of 1.6x and a net D/PI of 0.6x. GPP IV is a 2022 vintage $506 million fund. We also manage over $100 million in co-investments for our limited partners.BMVF which manages approximately $750 million and has a trailing 5 year net CAGR of approximately 12% net and 20 year of 14% net. A dollar invested in BMVF at inception in November of 2003 has appreciated approximately 14.0x versus 5.2x for the Russell 2000 Biotech index to date. BMVF was closed to new investors as well as to additional capital from existing investors for 3 years and in fact voluntarily distributed 5% of capital back to investors as of 12/31/17 in order to maximize ROI, not AUM/management fees.
-
General Partner And Head Of Health Care InvestmentsJ.H. Whitney & Co. Aug 1993 - Sep 2003During my tenure J.H. Whitney & Co. grew from $500 million in lower middle market buy-out assets to over $7 billion. Health care represented about 20% of our investment activities. I led growth buy-outs of AdvancePCS, CRA Managed Care, Eon Labs, Symbion, U.S. Bioservices and numerous other health care companies and served on the firm's Investment Committee. While serving as Head of Health Care and an Investment Committee member for Whitney for over ten years, we produced four top quartile (exceeding Cambridge Associates IRR and TV/PI benchmarks) performance middle market buyout funds producing net internal rate of returns to investors of over 25%. Our Limited Partners included university endowments such as Caltech, Columbia, Dartmouth, Duke, Harvard, Michigan, MIT and Yale, foundations such as Carnegie, Dupont, Ford, Kresge and MacArthur and family offices such as Broad and the Olayan Group.
-
PrincipalCanaan Partners Dec 1988 - Aug 1993San Francisco, California, UsI led growth equity financings for rapidly growing health care companies such as Centocor and Mariner Health Group. Centocor was the most successful investment in Canaan I as measured by IRR and total dollars of capital appreciation for Limited Partners.
Jeffrey Jay, M.D., M.B.A. Skills
Jeffrey Jay, M.D., M.B.A. Education Details
-
Harvard Business SchoolGeneral -
The London School Of Economics And Political Science (Lse)Economics
-
Boston University School Of MedicineNeurosciences
-
St. John'S, Shrewsbury, MaBiology/Biological Sciences And Mathematics
Frequently Asked Questions about Jeffrey Jay, M.D., M.B.A.
What company does Jeffrey Jay, M.D., M.B.A. work for?
Jeffrey Jay, M.D., M.B.A. works for Great Point Partners
What is Jeffrey Jay, M.D., M.B.A.'s role at the current company?
Jeffrey Jay, M.D., M.B.A.'s current role is Founder and Managing Partner at Great Point Partners.
What is Jeffrey Jay, M.D., M.B.A.'s email address?
Jeffrey Jay, M.D., M.B.A.'s email address is jj****@****nds.com
What is Jeffrey Jay, M.D., M.B.A.'s direct phone number?
Jeffrey Jay, M.D., M.B.A.'s direct phone number is +120397*****
What schools did Jeffrey Jay, M.D., M.B.A. attend?
Jeffrey Jay, M.D., M.B.A. attended Harvard Business School, The London School Of Economics And Political Science (Lse), Boston University School Of Medicine, St. John's, Shrewsbury, Ma.
What are some of Jeffrey Jay, M.D., M.B.A.'s interests?
Jeffrey Jay, M.D., M.B.A. has interest in Politics, Education, Golf, Fishing, George's In England.
What skills is Jeffrey Jay, M.D., M.B.A. known for?
Jeffrey Jay, M.D., M.B.A. has skills like Private Equity, Investments, Hedge Funds, Venture Capital, Healthcare, Due Diligence, Entrepreneurship, Capital, Mergers, Growth Capital, Financial Modeling, Executive Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial